Tianfu Wen

机构：Sichuan University, West China Hospital of Sichuan University, Jiangxi Academy of Environmental Sciences · ORCID：0000-0003-1871-272X

发表论文 293 篇 · 总被引 6663 次 · h-index 33

代表论文

• Neoadjuvant therapy of sequential TACE, camrelizumab, and apatinib for single huge hepatocellular carcinoma (NEO-START): study protocol for a randomized controlled trial (2024 · Trials · 被引 13)
• Deriving hybrid reservoir group operation rules for droughts using integrated NSGA-II framework and operation models (2025 · Journal of Hydrology · 被引 8)
• Effect of short-term exercise-based prehabilitation program for patients undergoing liver cancer surgery: A randomized controlled trial (2025 · Surgery · 被引 8)
• Surgical treatment improves overall survival of hepatocellular carcinoma with extrahepatic metastases after conversion therapy: a multicenter retrospective study (2024 · Scientific Reports · 被引 8)
• 1469MO Liver resection versus continued atezolizumab plus bevacizumab (atezo/bev) in locally advanced hepatocellular carcinoma (HCC) after atezo/bev treatment (TALENTop): A multicenter, open-label, randomized phase III trial (2025 · Annals of Oncology · 被引 7)
• Adjuvant lenvatinib in combination with transarterial chemoembolization for hepatocellular carcinoma patients with high risk of postoperative recurrence: A multicenter prospective cohort study (2025 · Hepatobiliary & pancreatic diseases international · 被引 6)